58 parallel-computing-numerical-methods research jobs at University of Maryland, Baltimore
Sort by
Refine Your Search
-
presentations. The successful applicant will work in a multidisciplinary research team supported by an advanced data management and computational infrastructure to perform data analyses, develop and/or implement
-
. This 2-year project, funded by the American Cancer Society, focuses on a novel method of T cell radiolabeling and imaging to get an insight into T cell penetration to solid tumors, including brain cancer
-
all aspects of vaccine development. Education: PhD in microbiology, biochemistry, or related fields Preferred Experience: Demonstrated experience in laboratory science using molecular methods and
-
, along with additional exciting perks that employees can take advantage of. This position participates in a retirement program (pension), effective on your date of hire. Non-exempt regular staff receive a
-
for natural and drug reward. The Juarez lab uses circuit dissecting ex vivo and in vivo electrophysiology, fiber photometry, viral based CRISPR/Cas9 gene-editing, and methods to manipulate neural activity in
-
; Embraces and actively promotes an inclusive and equitable work environment. Experience conducting mixed-methods research, including quantitative and qualitative analytical skills; Proficient computer skills
-
of. This position participates in a retirement program (pension or optional retirement plan/ORP) that must be selected and is effective on your date of hire. Exempt regular staff receive a generous PAID leave package
-
. Ability to perform laboratory procedures usingapplicable equipment and techniques; to communicate effectively both orally and in writing; to use computers and related software applications; to lift
-
integration of transplanted stem cells. We expect the fellow to be highly motivated, independent and innovative. The applicant can expect to receive career mentoring from faculty of the Program of Image Guided
-
a dynamic, translational research program focused on engineering oncolytic viruses to target pancreatic ductal adenocarcinoma (PDAC) and modulate the tumor microenvironment for enhanced immunotherapy